Bruce Lindsay, MD

216.444.6697

Bruce Lindsay, MD

Appointed: 2008

Bruce Lindsay, MD
Department: Cardiovascular Medicine
Section Head
Location: Cleveland Clinic Main Campus
Mail Code J2-2
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
WorkFax:216.445.6195
Bruce Lindsay, MD
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code J2-2
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
WorkFax:216.445.6195
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Bruce D. Lindsay is Section Head, Cardiac Electrophysiology and Pacing at the Cleveland Clinic. He served as President of the Heart Rhythm Society 2007-2008 and chaired the Heart Rhythm Society's Annual Scientific Program in Boston in 2006, which was attended by more than 13,000 international physicians, scientists, and allied health professionals.  Dr. Lindsay recently completed a term on Board of Trustees for the American College of Cardiology, and formerly chaired the College's Board of Governors. He also serves on the ABIM test writing committee for Clinical Cardiac Electrophysiology.

 Dr. Lindsay is a graduate of Jefferson Medical College and completed a residency in internal medicine at the University of Michigan. He served in the National Health Service Corps from 1980-83.  He completed a cardiology fellowship at Washington University where he undertook additional training in the treatment of heart rhythm disorders. He joined the faculty at Washington University in 1985 and became Professor of Medicine and Director of Electrophysiology. He accepted the position of Section Head, Cardiac Electrophysiology and Pacing at the Cleveland Clinic in 2008.

 His clinical research and publications have focused on identification of patients at increased risk for cardiac arrest, improved technology for implantable defibrillators, malfunctions of implantable cardiac devices, and advances in ablation of heart rhythm abnormalities. He is a contributing author for the Heart Rhythm Society state of the art consensus document for ablation of atrial fibrillation.  Through his commitment to education he has served on the faculty at meetings throughout the United States, Europe, Japan, Taiwan, and China.

Professional Highlights

  • Past President, Heart Rhythm Society 2007-2008
  • Board of Trustees, Heart Rhythm Society 2001-present
  • Program Chair, Annual Scientific Sessions of Heart Rhythm Society 2006
  • Chair, Board of Governors, American College of Cardiology 2001
  • Board of Trustees, American College of Cardiology 2000-2008

Education & Fellowships

Fellowship - Barnes-Jewish Hospital
Cardiac Electrophysiology
St. Louis, MO USA
1986
Fellowship - Barnes-Jewish Hospital
Cardiology
St. Louis, MO USA
1985
Residency - University of Michigan Health System
Medicine
Ann Arbor, MI USA
1980
Internship - University of Michigan Health System
Medicine
Ann Arbor, MI USA
1978
Medical School - Jefferson Medical College of Thomas Jefferson University
Philadelphia, PA USA
1977

Certifications

  • Internal Medicine
  • Internal Medicine- Cardiovascular Disease
  • Internal Medicine- Clinical Cardiac Electrophysiology

Specialty Interests

Abnormal Heart Rhythms, Long QT Syndrome, Atrial Fibrillation, Supraventricular Tachycardia, Sudden Cardiac Death, Ventricular Tachycardia, Biventricular Pacemaker, Catheter Ablation, Implantable Cardioverter Defibrillator, Pacemaker Implant, Pulmonary Vein Isolation Ablation

Awards & Honors

Top Doctors

Innovations & Patents

Magnetic catheter navigation for ablation of atrial and ventricular arrhythmias

Memberships

  • Heart Rhythm Society
  • American College of Cardiology
  • American Heart Association

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/27/2014, Dr. Lindsay has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Lindsay received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Medtronic, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site